← Back to patent-cliff list
Seratrodast
Tier C — Watch / tradeSeratrodast
Takeda Pharmaceutical Company Limited
Originator
1995
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：TBXA2R
Brand：Bronica
Indications (approved)：Asthma
Regional status
US
-
EU
-
China
Approved
2003-10-10
Japan
Approved
1995-01-01
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Seratrodast?
Approved indications include: Asthma.
When does the Seratrodast patent expire?
No public expiry year is available for Seratrodast yet; this page updates once verified.
How do I get a quote for Seratrodast intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04